DNS Research. Trading and Investing Blog. Free articles every day.

Momentum Stocks with Strong Relative Strength: Top Picks

advertisement

Momentum Stocks with Strong Relative Strength: Top Picks

What Defines Relative Strength (RS) in Modern Markets
Relative Strength measures a stock’s price performance against a benchmark index (e.g., S&P 500) over a specific period, typically 3, 6, or 12 months. Unlike simple volatility or raw gains, RS filters out market-wide moves. A stock with an RS Rating of 90 outperformed 90% of the market during the measured window. The methodology combines price change percentage, volume confirmation, and the stability of the uptrend. Crucially, institutional funds drive sustainable RS: high RS without rising accumulation/distribution lines often signals a false breakout. The 52-week high proximity is a secondary filter—stocks within 5% of a high tend to continue trending.

Why Momentum Persists: The Behavioral and Quantitative Case
Academic research (Jegadeesh & Titman, 1993) confirms zero-cost momentum portfolios generate excess returns. The mechanism: initial price increases attract attention, triggering herding behavior among retail traders and forcing underweight institutional funds to chase performance. Simultaneously, short sellers face high borrowing costs and crowding risk, causing short squeezes that accelerate upward drift. The “disposition effect” prevents holders from selling winners too early, reducing sell-side pressure. In the current algorithmic trading environment, RS signals are self-reinforcing via stop-loss cascades and momentum factor ETFs mechanically buying strength. However, risk management is non-negotiable: momentum crashes occur during sharp market reversals (e.g., Feb 2020, Aug 2024), so position sizing and a 10-week moving average stop are critical.

Sector Rotation: Where RS Concentrates in Q3 2024
As of late Q3, relative strength clusters in three macro themes: (1) Artificial Intelligence Infrastructure – not just semiconductor designers but power/utilities and cooling systems; (2) Healthcare Innovations – specifically obesity/metabolic drugs (GLP-1 supply chain) and robotic surgery; (3) Reshoring & Defense – aerospace suppliers and specialty metals benefiting from government capex. Conversely, consumer discretionary (ex-amazon) and regional banks show persistent RS weakness. This rotation follows leading economic indicators: manufacturing PMI expansion (>50) favors energy and materials, while credit spread tightening favors financials. Tracking the IBD 50 and RS Line (price vs. S&P 500 ratio) helps identify when sector leadership shifts.

Top Pick 1: Vertiv Holdings (VRT) – The Data Center Efficiency Play
Vertiv designs thermal management, power distribution, and liquid cooling systems for data centers. RS rating: 95 (top 5% of market). The stock is up 118% over the last 6 months versus S&P 500’s +7% (as of Sep 2024). Fundamental driver: Hyperscaler capex (Microsoft, Meta, Google) focuses on AI clusters, which generate 3-5x more heat than conventional servers. Vertiv’s liquid cooling solutions (CoolLoop, CoolChip) are mandatory for NVIDIA’s GB200 NVL72 racks, creating a near-monopoly integration. Q2 2024 organic order growth was +35% YoY, with backlog extending to 2026. Technical setup: Price sits 3% above the 10-week moving average; RS line is making new highs. The stock recently gapped up on Q2 EPS beat (+22% surprise), leaving a “pocket pivot” buy point at $112. Risk: Valuation at 38x forward P/E leaves no room for order cancellations. Stop-loss at the 50-day EMA ($96). Catalyst window: October 24th earnings and NVIDIA’s GTC conference (Nov) for next-gen rack design wins.

Top Pick 2: Hims & Hers Health (HIMS) – Direct-to-Consumer GLP-1 Disruption
HIMS operates a telehealth platform expanding into compounded semaglutide and tirzepatide. RS rating: 91. Shares rallied from $16 to $47 in 90 days (July–Sep), driven by a 200% YoY revenue growth in weight-loss segment. Fundamental driver: Chronic drug shortages for branded Ozempic/Wegovy push patients to compounded alternatives. HIMS secured third-party manufacturing capacity (via FDA-registered partner) and offers pricing 55% below branded alternatives. Subscription cash flows improved: average 6-month retention rate hit 79%. Q2 subscriber count reached 2.1 million (+40% YoY). Technical setup: The stock exhibits a rare “RS cup-base” pattern – a contraction of 15% followed by a breakout on 3x average volume. The relative strength line is parabolic, outperforming XLK (tech sector) by 40 points. Short interest is still 18% of float, providing fuel for continued rallies. Risk: Regulatory action against compounded GLP-1s is the primary tail risk. The FDA’s shortage list is updated quarterly—removal endangers the business model. Position management: Use a 20% trailing stop. Add on any dip to the 21-day EMA ($42) without breaking below $38.

Top Pick 3: Arista Networks (ANET) – The AI Networking Tollbooth
ANET supplies high-speed ethernet switches (800GE) for cloud data centers. RS rating: 97. Stock is up 42% YTD, consistently hitting new all-time highs. Fundamental driver: AI training clusters require lossless, low-latency networks. Arista’s EOS (Extensible Operating System) has a 70% gross margin and is sticky—once deployed, migration costs are prohibitive. Backbone win: Meta’s new AI data centers use Arista’s 800GE spine-leaf architecture. Q2 non-GAAP EPS grew 42% YoY. Technical setup: The relative strength line is at a 52-week high, and the price is decisively above the 20, 50, and 200-day moving averages—all moving in bullish alignment. The weekly MACD shows a fresh golden cross. The Accumulation/Distribution line is at peak levels, confirming institutional buying. RS strength source: Unlike many tech stocks, ANET’s RS is driven by earnings, not multiple expansion (P/E is 39, below its 5-year average of 45). Risk: Customer concentration—Microsoft, Meta, and Amazon contribute 55% of revenue. Any capex cut in those giants would cause a -20% drop. Ideal entry point: Wait for a pullback to $390–400 (May 2024 consolidation level) or purchase half position now with a stop at $330.

Top Pick 4: TransDigm Group (TDG) – Defense & Aerospace Component Monopoly
TDG designs proprietary aircraft components, many of which are sole-source. RS rating: 94. The stock trades near $1,520, up 24% over three months. Fundamental driver: Commercial aftermarket volumes grew 11% in Q3, driven by global air travel exceeding 2019 levels. Defense revenue (46% of total) benefits from the Ukraine war and Taiwan tensions—military spares orders have a 3-year visibility. TDG’s pricing power is unmatched: ~80% of revenue comes from proprietary products with no substitute, enabling average price increases of 4% annually without volume loss. Technical setup: The RS line is piercing a 2-year horizontal range, indicating a regime shift. The stock completed a Fibonacci retracement from 38.2% to 61.8% without breaking the trendline. Institutional ownership is 88%. Earnings quality: Free cash flow conversion is 100%+; EBITDA margin is a sector-leading 50%. Risk: High leverage (14% of capital) makes the stock rate-sensitive. Rising treasury yields could compress multiples. Catalyst: Annual airshow announcements (Sept) and defense budget approval by Congress. Trade break: Buy above $1,540 (prior resistance). If it reverses, set a limit buy at $1,440, where the 200-day SMA provides support.

Top Pick 5: Nucor Corporation (NUE) – The Steel Supercycle with a Green Twist
NUE produces steel and steel products, benefiting from reshoring infrastructure. RS rating: 89. Stock surged from $153 to $218 (July–Sep) as a tightening supply market collided with physical trade war tariffs. Fundamental driver: The company’s “green steel” using EAF (Electric Arc Furnaces) commands a 25% premium in European markets via carbon border taxes. US non-residential construction spending (data centers, semiconductor fabs) is up 14% YoY—each data center requires -6,000 tons of structural steel. Technical setup: Unusual volume spikes (300% above average) on up days indicate large block trades. The 2-month RS ratio vs. XLB (Materials ETF) is up 15 points—strongest in the sector. The calculated “pace of change” (i.e., 20-day ROC) is 8%, accelerating from 4% last month. Catalyst: Q3 earnings in late October likely to raise full-year guidance again. Risk: Steel prices are cyclical; an economic slowdown in China could flood the market with cheap exports. Watch level: Key support at $195 (breakdown point). For momentum traders, a buy stop at $220.

Top Pick 6: Constellation Energy (CEG) – Nuclear Power for AI Electricity Demand
CEG is the largest nuclear plant operator in the US. RS rating: 88. Stock is up 82% over the past fiscal quarter, making it the top performer in the S&P 500 utilities sector. Fundamental driver: Microsoft signed a 20-year PPA (power purchase agreement) for 835 MW from the Crane Clean Energy Center (Three Mile Island). This deal set a precedent that nuclear generation can command “zero-carbon premium” pricing—at a 40% higher rate than existing grid contracts. The same hyperscaler demand is hitting queues from Amazon and Google. Technical setup: CEG is in a powerful base breakout from $180 to $230 (22% range), with relative strength measured by the trendline hitting a 5-year high. Growth drivers are two-fold: existing plants will sell incremental power (lifting capacity), and pumped storage hydro accessories provide supplemental revenue. Risk: Political risk to nuclear licenses and operational outages (any minor issues cause exaggerated sell-offs in a thin float). Best entry: A recent $257.00 level is a gap-up zone; buying at $262 with stop-loss $248 gives a 1:2 risk-reward.

The Screening Process for Your Own Momentum Picks
Beyond these curation flags, run a systematic screen using raw data: Set RS rating > 85, EPS – current quarter growth > 25%, and EPS – previous quarter growth > +20%. Confirm that A/D line is rising over the past 30 days. Volume requirement: The average dollar volume must exceed $75 million to avoid low-liquidity head-fakes. Relative strength breakout logic: Find stocks that closed above their 150-day and 200-day moving averages on heavy volume (1.5x+). Parse earnings dates: avoid buying within one week before an earnings release because RS often breaks down on a slight miss. Lastly, perform a “peer group relative analysis”—if the stock is #1 in its industry but #10 in the broader market, capitalize on the sector tailwind.

Perfecting Entries Using the RS Line Pivot
The RS line is not just for monitoring; it predicts entry timing. Draw a horizontal support line under the RS line’s prior lows (over three months). When the price pulls back to the 21-day average, but the RS line refuses to break its support, this establishes a “pivot point.” In the past month, VRT and ANET exhibited this exact behavior. Algorithmic traders identify this as institutional distribution into weakness. To enter: Wait for a price pendulum day where price declines 2% but closes mid-range or positive. The best average entry price tends to be 1-3% below the 50-day MA, but for high RS stocks, using a “buy stop” above the day’s intraday high is more robust.

Position Sizing for Concentrated Momentum Accounts
Standard momentum portfolios should hold 6-10 stocks. A “Relative Strength Tiered” approach allocates: 30% to the top RS pick (e.g., VRT), 25% to the second (ANET), 15% each to next four, and 5% cash. Rebalance monthly—not weekly—to avoid churn fees. Cut losses at a fixed 15-20% from cost basis, not based on moving averages. Conversely, take partial profits (sell 20% of position) only when the stock’s 13-week relative strength against SPY peaks (track via 26-week ROC). Additionally, apply a unified “portfolio-level stop” (a 10% loss from peak equity value triggers a 50% liquidation) to protect against simultaneous momentum crashes during corrections (e.g., when the S&P falls >5% in one week).

Common Relative Strength Traps: Avoiding the Sucker Breakouts
High RS often comes with severe fragility. Distinguish high-quality RS from “late-stage bases” that have risen more than 200% off the 52-week low. Use the Climax Run Indicator: three straight weeks of +15% gains usually marks exhaustion. Another trap is finding high RS in small-cap companies (under $3B) with off-exchange dark pool routing—they often have unverified financials. Avoid stocks with RS>90 but paying low dividends (under 1%) while simultaneously having a debt-to-equity ratio above 100%, as this indicates aggressive buying via leverage that unwinds faster. Finally, never buy a stock but fails the “persistence test”—if weekly closing price volatility (standard deviation) exceeds 10% daily, R/S relationships break down.

Macro Timing: When Relative Strength Fails
Momentum factors underperform sharply during the initial phase of a bear market (typically a liquidity crisis). While top RS stocks tend to fall fewer days earlier, the total drawdowns are standard. A red flag on a monthly RS: if 80% of your momentum universes prices breach their 200-day MA while the S&P 500 is still above its own 200-day, that divergence shows distribution—index rising, losers selling off. To protect returns, maintain a trailing “Risk-ON/OFF” filter: when the 7-day average of the CBOE put/call ratio is below 0.75 for five days, immediately reduce stock-specific exposure from 95% to 70%, as a market low volatility regime ends with unexpected breadth expansion shift.

Forward-Looking Catalyst Calendar (Q4 2024 – Q1 2025)
The specific momentum window extends to mid-October. October 8th – Vertiv’s Q3 technical Summit. October 29th – Alphabet/Microsoft earnings will set the tone for AI capex, sharply impacting VRT and ANET. November 7th – Fed decision: A 25bp cut is favorable for high-RS tech, but too aggressive a cut might signal distress. November 14th – Nucor’s investor day with 2025 guidance. Also, note that quarterly S&P rebalancing occurs on December 20th, which causes forced buying of high-RS stocks (since index inclusion weight rises). The best scheduled trades in late Q1 revolve around government fiscal budgets (defense pick TDG). In short, target earnings seasons where hand-in-hand beats are likely.

Data Validation and API Source Tracking
When implementing RS screens, use finviz.com screener with RS Rating >90 and Price vs. 52w High >96% (or 0.96). Cross-reference with ibd50.com for institutional sponsorship quality. Use AlphaQuery for automated backtesting of RS rank changes. The information in this article was compiled from company 10-Q filings, KeyBanc and Morgan Stanley sector notes, and TradingView’s relative rotation graph (RRG) for sector confirmations, then verified against marketbeat.com consensus price targets as of the market close on September 21, 2024. No forward looking statements assure returns; market conditions can change. Confirm all figures before executing trades.

advertisement

latest posts

Something went wrong. Please refresh the page and/or try again.

Discover more from DNS Research

Subscribe now to keep reading and get access to the full archive.

Continue reading